The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Oxytocin Injection-Global Market Insights and Sales Trends 2025
Synopsis
Oxytocin injection is a synthetic form of oxytocin, a hormone that is naturally produced by the pituitary gland in the brain. Oxytocin is responsible for stimulating uterine contractions during labor and milk ejection during breastfeeding . Oxytocin injection is used to induce or augment labor, to control postpartum bleeding, or to terminate pregnancy . Oxytocin injection is administered intravenously or intramuscularly by a health care professional . According to the U.S. Food and Drug Administration, oxytocin injection is defined as “a sterile, clear, colorless aqueous solution of synthetic oxytocin, for intravenous infusion or intramuscular injection.
The global Oxytocin Injection market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Oxytocin Injection in various end use industries. The expanding demands from the Animal Use and Human Use, are propelling Oxytocin Injection market. Oxytocin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Carbetocin segment is estimated at % CAGR for the next seven-year period.
The industry trend of oxytocin injection is influenced by several factors, such as:
The increasing demand for oxytocin injection in various regions of the world, especially in low- and middle-income countries where maternal mortality and morbidity are high due to complications of childbirth .
The growing awareness of the benefits and risks of oxytocin injection among consumers and health professionals, which encourages the appropriate use and regulation of oxytocin injection for different indications .
The advancement of technology and innovation that enable the improvement of oxytocin injection quality, safety, efficacy, and accessibility .
Some examples of the industry trend of oxytocin injection are:
The emergence of new applications of oxytocin injection in different fields, such as psychiatry, neurology, and oncology .
The development of new formulations and delivery systems of oxytocin injection that enhance its stability, bioavailability, and convenience .
The introduction of new standards and guidelines that ensure the quality and safety of oxytocin injection in the global market .
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oxytocin Injection, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oxytocin Injection market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oxytocin Injection market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oxytocin Injection sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oxytocin Injection covered in this report include JHP Pharmaceuticals, Grindex, Pfizer, Novartis, GSK, Bimeda, Bayer, Agrilab and Kepro B.V., etc.
The global Oxytocin Injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
JHP Pharmaceuticals
Grindex
Pfizer
Novartis
GSK
Bimeda
Bayer
Agrilab
Kepro B.V.
Hybio Pharmaceutical
Shanghai Hefeng
Renjian Pharmaceutical
Global Oxytocin Injection market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oxytocin Injection market, Segment by Type:
Oxytocin
Carbetocin
Global Oxytocin Injection market, by Application
Animal Use
Human Use
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Oxytocin Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Oxytocin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Oxytocin injection is a synthetic form of oxytocin, a hormone that is naturally produced by the pituitary gland in the brain. Oxytocin is responsible for stimulating uterine contractions during labor and milk ejection during breastfeeding . Oxytocin injection is used to induce or augment labor, to control postpartum bleeding, or to terminate pregnancy . Oxytocin injection is administered intravenously or intramuscularly by a health care professional . According to the U.S. Food and Drug Administration, oxytocin injection is defined as “a sterile, clear, colorless aqueous solution of synthetic oxytocin, for intravenous infusion or intramuscular injection.
The global Oxytocin Injection market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Oxytocin Injection in various end use industries. The expanding demands from the Animal Use and Human Use, are propelling Oxytocin Injection market. Oxytocin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Carbetocin segment is estimated at % CAGR for the next seven-year period.
The industry trend of oxytocin injection is influenced by several factors, such as:
The increasing demand for oxytocin injection in various regions of the world, especially in low- and middle-income countries where maternal mortality and morbidity are high due to complications of childbirth .
The growing awareness of the benefits and risks of oxytocin injection among consumers and health professionals, which encourages the appropriate use and regulation of oxytocin injection for different indications .
The advancement of technology and innovation that enable the improvement of oxytocin injection quality, safety, efficacy, and accessibility .
Some examples of the industry trend of oxytocin injection are:
The emergence of new applications of oxytocin injection in different fields, such as psychiatry, neurology, and oncology .
The development of new formulations and delivery systems of oxytocin injection that enhance its stability, bioavailability, and convenience .
The introduction of new standards and guidelines that ensure the quality and safety of oxytocin injection in the global market .
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oxytocin Injection, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oxytocin Injection market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oxytocin Injection market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oxytocin Injection sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oxytocin Injection covered in this report include JHP Pharmaceuticals, Grindex, Pfizer, Novartis, GSK, Bimeda, Bayer, Agrilab and Kepro B.V., etc.
The global Oxytocin Injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
JHP Pharmaceuticals
Grindex
Pfizer
Novartis
GSK
Bimeda
Bayer
Agrilab
Kepro B.V.
Hybio Pharmaceutical
Shanghai Hefeng
Renjian Pharmaceutical
Global Oxytocin Injection market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oxytocin Injection market, Segment by Type:
Oxytocin
Carbetocin
Global Oxytocin Injection market, by Application
Animal Use
Human Use
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Oxytocin Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Oxytocin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Oxytocin Injection Market Overview
1.1 Oxytocin Injection Product Overview
1.2 Oxytocin Injection Market Segment by Type
1.2.1 Oxytocin
1.2.2 Carbetocin
1.3 Global Oxytocin Injection Market Size by Type
1.3.1 Global Oxytocin Injection Market Size Overview by Type (2018-2029)
1.3.2 Global Oxytocin Injection Historic Market Size Review by Type (2018-2023)
1.3.3 Global Oxytocin Injection Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Oxytocin Injection Sales Breakdown by Type (2018-2023)
1.4.2 Europe Oxytocin Injection Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Oxytocin Injection Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Oxytocin Injection Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Oxytocin Injection Sales Breakdown by Type (2018-2023)
2 Global Oxytocin Injection Market Competition by Company
2.1 Global Top Players by Oxytocin Injection Sales (2018-2023)
2.2 Global Top Players by Oxytocin Injection Revenue (2018-2023)
2.3 Global Top Players by Oxytocin Injection Price (2018-2023)
2.4 Global Top Manufacturers Oxytocin Injection Manufacturing Base Distribution, Sales Area, Product Type
2.5 Oxytocin Injection Market Competitive Situation and Trends
2.5.1 Oxytocin Injection Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Oxytocin Injection Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oxytocin Injection as of 2022)
2.7 Date of Key Manufacturers Enter into Oxytocin Injection Market
2.8 Key Manufacturers Oxytocin Injection Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Oxytocin Injection Status and Outlook by Region
3.1 Global Oxytocin Injection Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Oxytocin Injection Historic Market Size by Region
3.2.1 Global Oxytocin Injection Sales in Volume by Region (2018-2023)
3.2.2 Global Oxytocin Injection Sales in Value by Region (2018-2023)
3.2.3 Global Oxytocin Injection Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Oxytocin Injection Forecasted Market Size by Region
3.3.1 Global Oxytocin Injection Sales in Volume by Region (2024-2029)
3.3.2 Global Oxytocin Injection Sales in Value by Region (2024-2029)
3.3.3 Global Oxytocin Injection Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Oxytocin Injection by Application
4.1 Oxytocin Injection Market Segment by Application
4.1.1 Animal Use
4.1.2 Human Use
4.2 Global Oxytocin Injection Market Size by Application
4.2.1 Global Oxytocin Injection Market Size Overview by Application (2018-2029)
4.2.2 Global Oxytocin Injection Historic Market Size Review by Application (2018-2023)
4.2.3 Global Oxytocin Injection Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Oxytocin Injection Sales Breakdown by Application (2018-2023)
4.3.2 Europe Oxytocin Injection Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Oxytocin Injection Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Oxytocin Injection Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Oxytocin Injection Sales Breakdown by Application (2018-2023)
5 North America Oxytocin Injection by Country
5.1 North America Oxytocin Injection Historic Market Size by Country
5.1.1 North America Oxytocin Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Oxytocin Injection Sales in Volume by Country (2018-2023)
5.1.3 North America Oxytocin Injection Sales in Value by Country (2018-2023)
5.2 North America Oxytocin Injection Forecasted Market Size by Country
5.2.1 North America Oxytocin Injection Sales in Volume by Country (2024-2029)
5.2.2 North America Oxytocin Injection Sales in Value by Country (2024-2029)
6 Europe Oxytocin Injection by Country
6.1 Europe Oxytocin Injection Historic Market Size by Country
6.1.1 Europe Oxytocin Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Oxytocin Injection Sales in Volume by Country (2018-2023)
6.1.3 Europe Oxytocin Injection Sales in Value by Country (2018-2023)
6.2 Europe Oxytocin Injection Forecasted Market Size by Country
6.2.1 Europe Oxytocin Injection Sales in Volume by Country (2024-2029)
6.2.2 Europe Oxytocin Injection Sales in Value by Country (2024-2029)
7 Asia-Pacific Oxytocin Injection by Region
7.1 Asia-Pacific Oxytocin Injection Historic Market Size by Region
7.1.1 Asia-Pacific Oxytocin Injection Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Oxytocin Injection Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Oxytocin Injection Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Oxytocin Injection Forecasted Market Size by Region
7.2.1 Asia-Pacific Oxytocin Injection Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Oxytocin Injection Sales in Value by Region (2024-2029)
8 Latin America Oxytocin Injection by Country
8.1 Latin America Oxytocin Injection Historic Market Size by Country
8.1.1 Latin America Oxytocin Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Oxytocin Injection Sales in Volume by Country (2018-2023)
8.1.3 Latin America Oxytocin Injection Sales in Value by Country (2018-2023)
8.2 Latin America Oxytocin Injection Forecasted Market Size by Country
8.2.1 Latin America Oxytocin Injection Sales in Volume by Country (2024-2029)
8.2.2 Latin America Oxytocin Injection Sales in Value by Country (2024-2029)
9 Middle East and Africa Oxytocin Injection by Country
9.1 Middle East and Africa Oxytocin Injection Historic Market Size by Country
9.1.1 Middle East and Africa Oxytocin Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Oxytocin Injection Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Oxytocin Injection Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Oxytocin Injection Forecasted Market Size by Country
9.2.1 Middle East and Africa Oxytocin Injection Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Oxytocin Injection Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 JHP Pharmaceuticals
10.1.1 JHP Pharmaceuticals Company Information
10.1.2 JHP Pharmaceuticals Introduction and Business Overview
10.1.3 JHP Pharmaceuticals Oxytocin Injection Sales, Revenue and Gross Margin (2018-2023)
10.1.4 JHP Pharmaceuticals Oxytocin Injection Products Offered
10.1.5 JHP Pharmaceuticals Recent Development
10.2 Grindex
10.2.1 Grindex Company Information
10.2.2 Grindex Introduction and Business Overview
10.2.3 Grindex Oxytocin Injection Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Grindex Oxytocin Injection Products Offered
10.2.5 Grindex Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Oxytocin Injection Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pfizer Oxytocin Injection Products Offered
10.3.5 Pfizer Recent Development
10.4 Novartis
10.4.1 Novartis Company Information
10.4.2 Novartis Introduction and Business Overview
10.4.3 Novartis Oxytocin Injection Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Novartis Oxytocin Injection Products Offered
10.4.5 Novartis Recent Development
10.5 GSK
10.5.1 GSK Company Information
10.5.2 GSK Introduction and Business Overview
10.5.3 GSK Oxytocin Injection Sales, Revenue and Gross Margin (2018-2023)
10.5.4 GSK Oxytocin Injection Products Offered
10.5.5 GSK Recent Development
10.6 Bimeda
10.6.1 Bimeda Company Information
10.6.2 Bimeda Introduction and Business Overview
10.6.3 Bimeda Oxytocin Injection Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Bimeda Oxytocin Injection Products Offered
10.6.5 Bimeda Recent Development
10.7 Bayer
10.7.1 Bayer Company Information
10.7.2 Bayer Introduction and Business Overview
10.7.3 Bayer Oxytocin Injection Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Bayer Oxytocin Injection Products Offered
10.7.5 Bayer Recent Development
10.8 Agrilab
10.8.1 Agrilab Company Information
10.8.2 Agrilab Introduction and Business Overview
10.8.3 Agrilab Oxytocin Injection Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Agrilab Oxytocin Injection Products Offered
10.8.5 Agrilab Recent Development
10.9 Kepro B.V.
10.9.1 Kepro B.V. Company Information
10.9.2 Kepro B.V. Introduction and Business Overview
10.9.3 Kepro B.V. Oxytocin Injection Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Kepro B.V. Oxytocin Injection Products Offered
10.9.5 Kepro B.V. Recent Development
10.10 Hybio Pharmaceutical
10.10.1 Hybio Pharmaceutical Company Information
10.10.2 Hybio Pharmaceutical Introduction and Business Overview
10.10.3 Hybio Pharmaceutical Oxytocin Injection Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Hybio Pharmaceutical Oxytocin Injection Products Offered
10.10.5 Hybio Pharmaceutical Recent Development
10.11 Shanghai Hefeng
10.11.1 Shanghai Hefeng Company Information
10.11.2 Shanghai Hefeng Introduction and Business Overview
10.11.3 Shanghai Hefeng Oxytocin Injection Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Shanghai Hefeng Oxytocin Injection Products Offered
10.11.5 Shanghai Hefeng Recent Development
10.12 Renjian Pharmaceutical
10.12.1 Renjian Pharmaceutical Company Information
10.12.2 Renjian Pharmaceutical Introduction and Business Overview
10.12.3 Renjian Pharmaceutical Oxytocin Injection Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Renjian Pharmaceutical Oxytocin Injection Products Offered
10.12.5 Renjian Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Oxytocin Injection Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Oxytocin Injection Industrial Chain Analysis
11.4 Oxytocin Injection Market Dynamics
11.4.1 Oxytocin Injection Industry Trends
11.4.2 Oxytocin Injection Market Drivers
11.4.3 Oxytocin Injection Market Challenges
11.4.4 Oxytocin Injection Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Oxytocin Injection Distributors
12.3 Oxytocin Injection Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
